FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "May Apply" recommendation to Mono Pharmacare IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 1 | 0 | 0 | 0 |
% | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | May Apply |
[Dilip Davda] The company is a distributor for many giant pharma companies and has been doing well for the reported periods. Based on FY23 earnings, the issue appears aggressively priced. Well-informed investors may park funds for the medium to long-term rewards. Read detail review...
Mono Pharmacare Limited peer comparison with similar listed entities. (Standalone) (As on March 31, 2023)
Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
---|---|---|---|---|---|
EPS Basic | EPS Diluted | ||||
Mono Pharmacare Limited | 1.99 | 1.99 | 19.92 | 9.01 | |
Chandra Bhagat Pharma Limited | 1.20 | 1.20 | 36.42 | 112.50 | 3.29 |
Notes:
Mono Pharmacare IPO Reviews, analysis and views by popular members. Read Mono Pharmacare Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 3 | 0 | 1 | 1 |
% | 60.00 | 0.00 | 20.00 | 20.00 |
Member | Review |
---|---|
APL |
Apply for Long Term at Cut-off Price MUST SUBSCRIBE FOR LONG TERM. POSITIVE VISION August 25, 2023 12:54:04 PM |
B.M.SURANA IPO Guru (2700+ Posts, 5300+ Likes) |
Neutral Kuchh dum nahin lagta. |
IPOmentor (200+ Posts) |
Avoid High valuation. August 27, 2023 10:25:54 AM |
MONO |
Apply for Long Term at Cut-off Price A company with Good growth and Vision August 24, 2023 11:16:19 PM |
P.S |
Apply for Long Term at Cut-off Price Must subscribe. August 25, 2023 4:12:29 PM |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|